Subsequently, molecular experiments, cell experiments and animal model experiments confirmed that lncRNA LBX2-AS1 can recruit the TF RARα to foster the expression of FSTL3 to boost development of thyroid cancer. This evidence concerns the gene FSTL3 and thyroid gland carcinoma.